Pharmacokinetics is the exploration of what the body does to a Medicinal Product. Source: EU Clinical Trials Register
Paediatric Investigation Plan. Source: EU Clinical Trials Register
The PIP Addressee is the name given to the legal entity that has received the Agency’s decision on a Paediatric Investigation Plan (PIP). Source: EU Clinical Trials Register
A placebo is a control substance (a dummy treatment) that can be given, if provided for in the protocol, to a group of patients participating in the study. It allows researchers to test for the ‘placebo effect’. This is a …
The number of subjects planned to be enrolled for a Clinical Trial. Source: EU Clinical Trials Register
Plans for treatment or care after the subject has ended the participation in the trial, if not already provided in the protocol. Source: EU Clinical Trials Register
A medicinal product derived from human blood or human plasma. Source: EU Clinical Trials Register
Reasons for exclusion of subjects from the clinical trial from among the exclusion criteria described in the protocol. Source: EU Clinical Trials Register
This is a code designated by the sponsor who represents the name routinely used by the sponsor to identify the product in the Clinical Trial documentation. Source: EU Clinical Trials Register
In the absence of trade name this is the name routinely used by a sponsor to identify the IMP in the Clinical Trial Documentation. Source: EU Clinical Trials Register